Method for diagnosing neoplasia by detecting expression of PRAD1 cyclin
US5858655A · kind A · utility
76Cited by
3References
7Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 2, 1995 |
| Grant date | Jan 12, 1999 |
| Priority date | — |
| Expiry date | Jun 2, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A novel cyclin, termed prad1, is disclosed, along with the nucleic acid sequence that encodes human prad1. Antibodies that bind specifically to prad1 and cell lines and transgenic animals containing DNA that encodes prad1 are also disclosed. In addition, methods of using the antibodies or fragments of the nucleic acid sequence, for example, to diagnose a neoplastic condition by detecting expression of prad1 or to modulate cellular proliferation, are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.